MedPath
NMPA Approval

Emtricitabine Rilpivirine and Tenofovir Disoproxil Fumarate Tablets

H20150684

December 30, 2015

Drug Information

恩曲利替片

片剂

本品为片剂。每片含200mg恩曲他滨、27.5mg盐酸利匹韦林(相当于25mg利匹韦林)和300mg富马酸替诺福韦酯(相当于245mg替诺福韦酯)。

化学药品

December 30, 2015

December 29, 2020

Company Information

Applicant Company

Patheon Inc

333 Lakeside Drive, Foster City, California 94404, United States of America

Manufacturing Company

Patheon Inc

2100 Syntex Court,Mississauga,Ontario L5N 7K9,Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

恩曲利替片 - NMPA 批准文号 | MedPath